Birmingham Capital Management’s GSK GSK Stock Holding History

Birmingham Capital Management’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-4,000	Closed	-$235K	–	96
2019 Q4	$235K	Hold	4,000	–	–	0.1%	93
2019 Q3	$213K	Hold	4,000	–	–	0.1%	98
2019 Q2	$200K	Hold	4,000	–	–	0.09%	99
2019 Q1	$209K	Buy	+4,000	New	+$200K	0.09%	94
2018 Q4	–	Sell	-4,000	Closed	-$201K	–	94
2018 Q3	$201K	Sell	4,000 -200	-5%	-$10.2K	0.08%	102
2018 Q2	$212K	Hold	4,200	–	–	0.09%	96
2018 Q1	$205K	Buy	+4,200	New	+$196K	0.09%	98
2017 Q4	–	Sell	-4,280	Closed	-$217K	–	102
2017 Q3	$217K	Sell	4,280 -360	-8%	-$18.3K	0.09%	100
2017 Q2	$250K	Sell	4,640 -680	-13%	-$36.3K	0.1%	92
2017 Q1	$280K	Buy	5,320 +960	+22%	+$48.7K	0.11%	88
2016 Q4	$210K	Sell	4,360 -400	-8%	-$19.8K	0.09%	101
2016 Q3	$258K	Hold	4,760	–	–	0.11%	89
2016 Q2	$258K	Buy	4,760 +304	+7%	+$16K	0.11%	90
2016 Q1	$226K	Sell	4,456 -704	-14%	-$35.1K	0.09%	94
2015 Q4	$260K	Buy	5,160 +116	+2%	+$5.91K	0.11%	93
2015 Q3	$242K	Buy	+5,044	New	+$263K	0.11%	94

Other funds holding GSK

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $34.3B AUM 22.63% 1-Year Est. Return

Birmingham Capital Management's GSK Position: Q1 2020 in Review

Birmingham Capital Management sold out of GSK (GSK) in Q1 2020, closing a stake of 4,000 shares — an estimated $235K sold.

Birmingham Capital Management first reported a position in GSK in Q3 2015 and held it in 16 quarters. The position peaked at $280K in Q1 2017. 818 funds tracked by Wall St. Rank hold GSK as of Q1 2020.

Birmingham Capital Management reported no remaining GSK position as of Q1 2020 after selling out during the quarter.
Birmingham Capital Management sold 4,000 GSK shares in Q1 2020, an estimated $235K.
Birmingham Capital Management first reported a position in GSK in Q3 2015 and held it in 16 quarters.
Birmingham Capital Management's GSK position peaked at $280K in Q1 2017.
818 funds tracked by Wall St. Rank held GSK as of Q1 2020.

Based on Birmingham Capital Management's 13F filing for Q1 2020, filed 28 Apr 2020.